oxazoles has been researched along with Diabetes Mellitus, Type 1 in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (20.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (30.00) | 29.6817 |
| 2010's | 3 (30.00) | 24.3611 |
| 2020's | 2 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Honkimaa, A; Hyöty, H; Sioofy-Khojine, AB | 1 |
| Berggren, PO; Juntti-Berggren, L; Klitz, W; Lindquist, L; Niklasson, B | 1 |
| Fogarty, CL; Forsblom, C; Groop, PH; Holthöfer, H; Hyvönen, ME; Kuusela, S; Lassenius, MI; Lehto, M; Lehtonen, E; Lehtonen, S; Ristola, M; Saleem, MA; Saurus, P; Tienari, J | 1 |
| Gao, F; Hu, M; Zheng, C | 1 |
| Berggren, PO; Blixt, M; Holmberg, R; Juntti-Berggren, L; Klitz, W; Niklasson, B | 1 |
| Chen, MF; Cheng, JT; Chou, MT; Chung, HH; Yang, TT | 1 |
| Abed, YA; Al-Abed, Y; Cvetkovic, I; Fresta, M; Harhaji, L; Kim, J; Maksimovic-Ivanic, D; Mangano, K; Miljkovic, D; Momcilovic, M; Nicoletti, F; Popadic, D; Stosic-Grujicic, S | 1 |
| Berg, AK; Frisk, G; Korsgren, O; Olsson, A | 1 |
| Ketelslegers, JM; Lambert, AE; Mpoy, M; Vandeleene, B | 1 |
| Jacker, HJ | 1 |
2 review(s) available for oxazoles and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
Use of bedaquiline and delamanid in diabetes patients: clinical and pharmacological considerations.
Topics: Aged; Animals; Antitubercular Agents; Arrhythmias, Cardiac; Comorbidity; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diarylquinolines; Drug Interactions; Drug Monitoring; Humans; Hypoglycemic Agents; Middle Aged; Nitroimidazoles; Oxazoles; Polypharmacy; Risk Assessment; Risk Factors; Tuberculosis | 2016 |
[Antidiabetics. 42].
Topics: Adolescent; Adult; Aged; Biguanides; Carbutamide; Child; Child, Preschool; Diabetes Mellitus; Diabetes Mellitus, Type 1; Glucosamine; Humans; Hypoglycemic Agents; Infant; Insulin; Insulin, Long-Acting; Middle Aged; Oxazoles; Plants, Medicinal; Pyrazoles; Quinolines; Sulfadiazine; Sulfathiazoles; Tolbutamide; Triazines; Urea | 1969 |
8 other study(ies) available for oxazoles and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
A preclinical assessment to repurpose drugs to target type 1 diabetes-associated type B coxsackieviruses.
Topics: A549 Cells; Amides; Antiviral Agents; Azithromycin; Benzimidazoles; Coxsackievirus Infections; Diabetes Mellitus, Type 1; Drug Repositioning; Enterovirus B, Human; Fluoxetine; Guanidine; Humans; Immunoglobulin G; Lovastatin; Oxadiazoles; Oxazoles; Oximes; Pyrazines; Ribavirin; Sulfonamides | 2020 |
Effectiveness of Antivirals in a Type 1 Diabetes Model and the Move Toward Human Trials.
Topics: Adult; Alkynes; Animals; Antiviral Agents; Benzoxazines; Cyclopropanes; Diabetes Mellitus, Type 1; Humans; Male; Oxadiazoles; Oxazoles; Proof of Concept Study; Rats; Ribavirin | 2020 |
Podocyte apoptosis is prevented by blocking the Toll-like receptor pathway.
Topics: Acetates; Animals; Apoptosis; Diabetes Mellitus, Type 1; Humans; Lipopolysaccharides; Male; Mice; Mice, Inbred BALB C; Oxazoles; Podocytes; Protein Serine-Threonine Kinases; Pyruvate Dehydrogenase Acetyl-Transferring Kinase; Rats; Signal Transduction; Toll-Like Receptors | 2015 |
Antiviral treatments reduce severity of diabetes in Ljungan virus-infected CD-1 mice and delay onset in diabetes-prone BB rats.
Topics: Animals; Antibodies, Viral; Antiviral Agents; Diabetes Mellitus, Type 1; Drug Therapy, Combination; Humans; Immunologic Factors; Mice; Oxadiazoles; Oxazoles; Parechovirus; Picornaviridae Infections; Rats; Rats, Inbred BB; Ribavirin | 2009 |
Improvement of hyperphagia by activation of cerebral I(1)-imidazoline receptors in streptozotocin-induced diabetic mice.
Topics: Animals; Benzofurans; Cerebrum; Diabetes Mellitus, Type 1; Disease Models, Animal; Eating; Female; Humans; Hyperphagia; Hypothalamus; Imidazoles; Imidazoline Receptors; Male; Mice; Mice, Inbred BALB C; Neuropeptide Y; Oxazoles; Rilmenidine; Streptozocin | 2012 |
A potent immunomodulatory compound, (S,R)-3-Phenyl-4,5-dihydro-5-isoxazole acetic acid, prevents spontaneous and accelerated forms of autoimmune diabetes in NOD mice and inhibits the immunoinflammatory diabetes induced by multiple low doses of streptozoto
Topics: Acetates; Animals; Cell Line, Tumor; Cell Survival; Chromatography, High Pressure Liquid; Cyclophosphamide; Cytokines; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Enzyme-Linked Immunosorbent Assay; Immunohistochemistry; Immunologic Factors; Inflammation Mediators; Islets of Langerhans; Male; Mice; Mice, Inbred CBA; Mice, Inbred NOD; Molecular Structure; Nitric Oxide; Oxazoles; Reverse Transcriptase Polymerase Chain Reaction; Streptozocin | 2007 |
Antiviral treatment of Coxsackie B virus infection in human pancreatic islets.
Topics: Antiviral Agents; Cells, Cultured; Coxsackievirus Infections; Cytopathogenic Effect, Viral; Diabetes Mellitus, Type 1; Enterovirus B, Human; Humans; Insulin; Islets of Langerhans; Oxadiazoles; Oxazoles | 2007 |
Treatment of systemic hypertension in insulin-treated diabetes mellitus with rilmenidine.
Topics: Adrenergic beta-Agonists; Adult; Aged; Albuminuria; Blood Pressure; Diabetes Mellitus, Type 1; Electrocardiography; Female; Glucose; Humans; Hypertension; Lipid Metabolism; Male; Middle Aged; Oxazoles; Proteinuria; Rilmenidine | 1988 |